96 related articles for article (PubMed ID: 2632086)
1. Effect of gastric acidity on bioavailability of N,N-dimethylcarbamoylmethylalpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetate, a new prodrug-type anti-inflammatory agent.
Yamada I; Goda T; Kawata M; Mizuta H; Ogawa K; Yokobe T
Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3372-5. PubMed ID: 2632086
[TBL] [Abstract][Full Text] [Related]
2. [Dissolution properties and bioavailability of ground mixture of N,N-dimethylcarbamoylmethyl alpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]-pyridine-7-acetate with various pharmaceutical ingredients].
Yamada I; Kawata M; Shibata T; Ogawa K; Yokobe T
Yakugaku Zasshi; 1989 Dec; 109(12):932-7. PubMed ID: 2630636
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic behaviour in polymorphonuclear leucocytes of N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]- pyridine-7-acetate (Y-23023), a new prodrug type of anti-inflammatory agent, and indomethacin after oral administrations in rats.
Yamada I; Nagamatsu Y; Imayoshi T; Shibata M; Tsuji A
J Pharm Pharmacol; 1994 Jul; 46(7):614-6. PubMed ID: 7996395
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis, pharmacological activity and biopharmaceutical characteristics of alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetates].
Kawasaki K; Yamada I; Oe T; Tsuruda M; Terasawa M; Imayoshi T; Yasunaga Y; Goto K
Yakugaku Zasshi; 1989 Nov; 109(11):827-34. PubMed ID: 2614665
[TBL] [Abstract][Full Text] [Related]
5. [Application of gastric acidity-controlled beagle dog to bioavailability study of cinnarizine].
Yamada I; Goda T; Kawata M; Ogawa K
Yakugaku Zasshi; 1990 Apr; 110(4):280-5. PubMed ID: 2376821
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
Sagara K; Yamada I; Matsuura Y; Kawata M; Shibata M
Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
[TBL] [Abstract][Full Text] [Related]
7. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs.
Yamada I; Goda T; Kawata M; Shiotuki T; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3112-5. PubMed ID: 2085896
[TBL] [Abstract][Full Text] [Related]
8. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
Miner PB; Fort JG; Zhang Y
Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
[TBL] [Abstract][Full Text] [Related]
9. The bioavailability of diazepam from uncoated tablets in humans--Part II: effect of gastric fluid acidity.
Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A
Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):166-70. PubMed ID: 7076346
[TBL] [Abstract][Full Text] [Related]
10. Gastric antisecretory agents. 1. Antisecretory and antiulcer activity of 5H-[1]benzopyrano[2,3-b]pyridin-5-ylureas and 5H-[1]benzothiopyrano[2,3-b]pyridin-5-ylureas.
Bristol JA; Gold EH; Lovey RG; Long JF
J Med Chem; 1981 Aug; 24(8):927-32. PubMed ID: 7328596
[No Abstract] [Full Text] [Related]
11. Gastric antisecretory agents. 2. Antisecretory activity of 9-[(aminoalkyl)thio]-9H-xanthenes and 5-[(aminoalkyl)thio]-5H-[1]benzopyrano[2,3-b]pyridines.
Bristol JA; Gold EH; Gross I; Lovey RG; Long JF
J Med Chem; 1981 Aug; 24(8):1010-3. PubMed ID: 7328593
[TBL] [Abstract][Full Text] [Related]
12. Gastric pH profile and its control in fasting beagle dogs.
Yamada I; Mizuta H; Goda T; Haga K; Ogawa K
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2539-41. PubMed ID: 2605707
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion.
Kosugi Y; Yamamoto S; Sano N; Furuta A; Igari T; Fujioka Y; Amano N
J Pharm Sci; 2015 Sep; 104(9):2887-93. PubMed ID: 25720462
[TBL] [Abstract][Full Text] [Related]
14. The effect of gastric pH on the absorption of controlled-release theophylline dosage forms in humans.
Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Vashi VI; Hepp P; Hunt J
Pharm Res; 1993 Jul; 10(7):1037-45. PubMed ID: 8378245
[TBL] [Abstract][Full Text] [Related]
15. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
Hosny EA; el-Mahrouk GM; Gouda MW
Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of indomethacin capsules in humans (III): Correlation with bioavailability in beagle dogs.
Aoyagi N; Ogata H; Kaniwa N; Ejima A; Nakata H; Tsutsumi J; Fujita T; Amada I
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):578-84. PubMed ID: 4077308
[TBL] [Abstract][Full Text] [Related]
17. Effect of small intestinal transit time on gastrointestinal absorption of 2-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl ] ethyl acetate, a new non-steroidal anti-inflammatory agent.
Mizuta H; Kawazoe Y; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2825-8. PubMed ID: 2076568
[TBL] [Abstract][Full Text] [Related]
18. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.
Sommers DK; van Wyk M; Moncrieff J; Schoeman HS
Br J Clin Pharmacol; 1984 Oct; 18(4):535-9. PubMed ID: 6091711
[TBL] [Abstract][Full Text] [Related]
19. Influence of gastric acidity on the bioavailability of digoxin.
Cohen AF; Kroon R; Schoemaker R; Hoogkamer H; van Vliet A
Ann Intern Med; 1991 Oct; 115(7):540-5. PubMed ID: 1883123
[TBL] [Abstract][Full Text] [Related]
20. Gastric-acidity-controlled rabbits: control of gastric pH of rabbits by the use of antacids.
Takahashi T; Uezono Y; Nakanishi Y
Chem Pharm Bull (Tokyo); 1987 Apr; 35(4):1546-54. PubMed ID: 3652295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
